ONWARD

ONWARD is an international Life Sciences company headquartered in Eindhoven and develops neurostimulation therapies for spinal cord injury patients. These therapies aim to reactivate arm-hand coordination and walking ability as well as restore essential bodily functions such as blood pressure and bladder function.

Through this investment, Invest-NL contributes to improving the quality of life for spinal cord injury patients and further developing neurostimulation technology.